Trulicity Shows Superiority in Reducing Weight, A1CA1C, Blockbusters, Clinical Trials, Glycemic Control, R&D, Safety Data, Type 2 Diabetes, Weight ReductionLilly’s diabetes drug Trulicity hit the mark in a late-stage trial showing higher doses of the medication significantly reduced A1C from baseline versus the product’s approved once-weekly usage. Read more June 26, 2019/by BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2019-06-26 12:18:222019-06-26 13:08:02Trulicity Shows Superiority in Reducing Weight, A1C